D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$986M |
| 2 |
Sea Limited
SE
|
+$480M |
| 3 |
Snowflake
SNOW
|
+$441M |
| 4 |
Citigroup
C
|
+$422M |
| 5 |
Oracle
ORCL
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$575M |
| 2 |
Apple
AAPL
|
+$515M |
| 3 |
Mastercard
MA
|
+$506M |
| 4 |
Walt Disney
DIS
|
+$447M |
| 5 |
Alibaba
BABA
|
+$434M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.34% |
| 2 | Consumer Discretionary | 9.18% |
| 3 | Financials | 7.38% |
| 4 | Healthcare | 6.92% |
| 5 | Communication Services | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Cars.com
CARS
$660M
| $9.82M | 0.01% |
610,502
-303,086
| -33% | -$4.33M |
|
1552
Vanda Pharmaceuticals
VNDA
$314M
| $9.82M | 0.01% |
626,060
-199,840
| -24% | -$3.48M |
|
|
ISLE
1553
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
| $9.81M | 0.01% |
997,478
+255,233
| +34% | +$2.51M |
|
1554
TriNet
TNET
$2.94B
| $9.8M | 0.01% |
102,918
+93,652
| +1,011% | +$9.34M |
|
|
CRZN
1555
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
| $9.78M | 0.01% |
1,001,843
+251,843
| +34% | +$2.45M |
|
1556
Ero Copper
ERO
$2.73B
| $9.76M | 0.01% |
639,300
+143,900
| +29% | +$2.49M |
|
1557
General Dynamics
GD
$105B
| $9.76M | 0.01% |
46,816
+15,416
| +49% | +$3.11M |
|
1558
PUT
Thomson Reuters
TRI
$42.7B
| $9.75M | 0.01% |
77,349
+47,453
| +159% | +$5.91M |
|
1559
Accel Entertainment
ACEL
$1.01B
| $9.75M | 0.01% |
748,601
+78,094
| +12% | +$992K |
|
|
RYZ
1560
Ryerson Holding Corp
RYZ
$1.59B
| $9.74M | 0.01% |
373,819
-37,911
| -9% | -$953K |
|
1561
CALL
Synopsys
SNPS
$74.5B
| $9.73M | 0.01% |
+26,400
| New | +$8.9M |
|
|
HCAR
1562
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
| $9.7M | 0.01% |
+993,959
| New | +$9.71M |
|
1563
Dr. Reddy's Laboratories
RDY
$9.8B
| $9.7M | 0.01% |
741,335
+298,610
| +67% | +$3.76M |
|
1564
Genpact
G
$5.45B
| $9.7M | 0.01% |
182,682
-30,810
| -14% | -$1.55M |
|
1565
CALL
Asana
ASAN
$1.79B
| $9.69M | 0.01% |
130,000
+40,000
| +44% | +$4.24M |
|
1566
Theravance Biopharma
TBPH
$874M
| $9.68M | 0.01% |
876,463
+456,412
| +109% | +$3.98M |
|
|
FTCH
1567
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $9.67M | 0.01% |
289,167
-1,739,980
| -86% | -$63.9M |
|
1568
CALL
Dillards
DDS
$8.96B
| $9.65M | 0.01% |
39,400
+10,000
| +34% | +$2.63M |
|
1569
Shutterstock
SSTK
$216M
| $9.65M | 0.01% |
87,035
+7,721
| +10% | +$898K |
|
1570
Editas Medicine
EDIT
$411M
| $9.64M | 0.01% |
363,133
+231,386
| +176% | +$7.96M |
|
|
QFTA
1571
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
| $9.64M | 0.01% |
974,352
+399,700
| +70% | +$3.94M |
|
1572
CALL
Ameriprise Financial
AMP
$47.6B
| $9.62M | 0.01% |
+31,900
| New | +$9.44M |
|
|
MVLA
1573
DELISTED
Movella Holdings Inc. Common Stock
MVLA
| $9.6M | 0.01% |
990,061
+865,061
| +692% | +$8.53M |
|
1574
Unisys
UIS
$245M
| $9.6M | 0.01% |
466,637
-37,637
| -7% | -$828K |
|
|
PIAI
1575
DELISTED
Prime Impact Acquisition I
PIAI
| $9.59M | 0.01% |
974,180
+71,791
| +8% | +$705K |
|
Similar funds
D.E. Shaw & Co's Q4 2021 Portfolio in Review
As of Q4 2021, D.E. Shaw & Co held 5,958 positions worth $121B, up 8.8% from $111B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co's Q4 2021 filing shows 1,033 new, 1,969 increased, 1,595 reduced and 616 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B. The largest sale was Microsoft, an estimated $575M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- D.E. Shaw & Co's largest Q4 2021 buy was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B.
- D.E. Shaw & Co added most to Sea Limited in Q4 2021, an estimated $480M increase.
- D.E. Shaw & Co's biggest Q4 2021 reduction was Microsoft, cutting an estimated $575M.
- D.E. Shaw & Co fully exited Aon in Q4 2021, selling an estimated $179M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $121B portfolio in Q4 2021.
- D.E. Shaw & Co opened 1,033 new positions and closed 616 in Q4 2021.
- D.E. Shaw & Co's portfolio value rose 8.8% quarter-over-quarter to $121B.
Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.